Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 2Gynecologic 1

Conditions

Uterine Prolapse 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Metrorrhagia 1Fallopian Tube Neoplasms 1Endometriosis 1Endometrial Neoplasms 1

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 90Cisplatin 67Specimen Handling 62Magnetic Resonance Spectroscopy 51olaparib 50Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Letrozole 26Doxorubicin 26Topotecan 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21Disulfides 20durvalumab 19Surveys and Questionnaires 19dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sutures × Gynecologic × 1 year × Clear all
NCT06024109 2026-06-02

BARHYSTER

Aesculap AG

Recruiting
132 enrolled
Gynecologic

Uterine Cervical Neoplasms, Endometriosis, Fallopian Tube Neoplasms, Metrorrhagia, Ovarian Neoplasms, Uterine Neoplasms, Uterine Prolapse, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡